Cargando…

JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma

T-cell/histiocyte-rich large B-cell lymphoma is a rare aggressive lymphoma showing histopathological overlap with nodular lymphocyte-predominant Hodgkin lymphoma. Despite differences in tumor microenvironment and clinical behavior, the tumor cells of both entities show remarkable similarities, sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuhmacher, Bianca, Bein, Julia, Rausch, Tobias, Benes, Vladimir, Tousseyn, Thomas, Vornanen, Martine, Ponzoni, Maurilio, Thurner, Lorenz, Gascoyne, Randy, Steidl, Christian, Küppers, Ralf, Hansmann, Martin-Leo, Hartmann, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355500/
https://www.ncbi.nlm.nih.gov/pubmed/30213827
http://dx.doi.org/10.3324/haematol.2018.203224
_version_ 1783391342763704320
author Schuhmacher, Bianca
Bein, Julia
Rausch, Tobias
Benes, Vladimir
Tousseyn, Thomas
Vornanen, Martine
Ponzoni, Maurilio
Thurner, Lorenz
Gascoyne, Randy
Steidl, Christian
Küppers, Ralf
Hansmann, Martin-Leo
Hartmann, Sylvia
author_facet Schuhmacher, Bianca
Bein, Julia
Rausch, Tobias
Benes, Vladimir
Tousseyn, Thomas
Vornanen, Martine
Ponzoni, Maurilio
Thurner, Lorenz
Gascoyne, Randy
Steidl, Christian
Küppers, Ralf
Hansmann, Martin-Leo
Hartmann, Sylvia
author_sort Schuhmacher, Bianca
collection PubMed
description T-cell/histiocyte-rich large B-cell lymphoma is a rare aggressive lymphoma showing histopathological overlap with nodular lymphocyte-predominant Hodgkin lymphoma. Despite differences in tumor microenvironment and clinical behavior, the tumor cells of both entities show remarkable similarities, suggesting that both lymphomas might represent a spectrum of the same disease. To address this issue, we investigated whether these entities share mutations. Ultra-deep targeted resequencing of six typical and 11 histopathological variants of nodular lymphocyte-predominant Hodgkin lymphoma, and nine cases of T-cell/histiocyte-rich large B-cell lymphoma revealed that genes recurrently mutated in nodular lymphocyte-predominant Hodgkin lymphoma are affected by mutations at similar frequencies in T-cell/histiocyte-rich large B-cell lymphoma. The most recurrently mutated genes were JUNB, DUSP2, SGK1, SOCS1 and CREBBP, which harbored mutations more frequently in T-cell/histiocyte-rich large B-cell lymphoma and the histopathological variants of nodular lymphocyte-predominant Hodgkin lymphoma than in its typical form. Mutations in JUNB, DUSP2, SGK1 and SOCS1 were highly enriched for somatic hypermutation hotspot sites, suggesting an important role of aberrant somatic hypermutation in the generation of these somatic mutations and thus in the pathogenesis of both lymphoma entities. Mutations in JUNB are generally rarely observed in malignant lymphomas and thus are relatively specific for nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma at such high frequencies (5/17 and 5/9 cases with JUNB mutations, respectively). Taken together, the findings of the present study further support a close relationship between T-cell/histiocyte-rich large B-cell lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma by showing that they share highly recurrent genetic lesions.
format Online
Article
Text
id pubmed-6355500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ferrata Storti Foundation
record_format MEDLINE/PubMed
spelling pubmed-63555002019-02-14 JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma Schuhmacher, Bianca Bein, Julia Rausch, Tobias Benes, Vladimir Tousseyn, Thomas Vornanen, Martine Ponzoni, Maurilio Thurner, Lorenz Gascoyne, Randy Steidl, Christian Küppers, Ralf Hansmann, Martin-Leo Hartmann, Sylvia Haematologica Article T-cell/histiocyte-rich large B-cell lymphoma is a rare aggressive lymphoma showing histopathological overlap with nodular lymphocyte-predominant Hodgkin lymphoma. Despite differences in tumor microenvironment and clinical behavior, the tumor cells of both entities show remarkable similarities, suggesting that both lymphomas might represent a spectrum of the same disease. To address this issue, we investigated whether these entities share mutations. Ultra-deep targeted resequencing of six typical and 11 histopathological variants of nodular lymphocyte-predominant Hodgkin lymphoma, and nine cases of T-cell/histiocyte-rich large B-cell lymphoma revealed that genes recurrently mutated in nodular lymphocyte-predominant Hodgkin lymphoma are affected by mutations at similar frequencies in T-cell/histiocyte-rich large B-cell lymphoma. The most recurrently mutated genes were JUNB, DUSP2, SGK1, SOCS1 and CREBBP, which harbored mutations more frequently in T-cell/histiocyte-rich large B-cell lymphoma and the histopathological variants of nodular lymphocyte-predominant Hodgkin lymphoma than in its typical form. Mutations in JUNB, DUSP2, SGK1 and SOCS1 were highly enriched for somatic hypermutation hotspot sites, suggesting an important role of aberrant somatic hypermutation in the generation of these somatic mutations and thus in the pathogenesis of both lymphoma entities. Mutations in JUNB are generally rarely observed in malignant lymphomas and thus are relatively specific for nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma at such high frequencies (5/17 and 5/9 cases with JUNB mutations, respectively). Taken together, the findings of the present study further support a close relationship between T-cell/histiocyte-rich large B-cell lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma by showing that they share highly recurrent genetic lesions. Ferrata Storti Foundation 2019-02 /pmc/articles/PMC6355500/ /pubmed/30213827 http://dx.doi.org/10.3324/haematol.2018.203224 Text en Copyright © 2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
spellingShingle Article
Schuhmacher, Bianca
Bein, Julia
Rausch, Tobias
Benes, Vladimir
Tousseyn, Thomas
Vornanen, Martine
Ponzoni, Maurilio
Thurner, Lorenz
Gascoyne, Randy
Steidl, Christian
Küppers, Ralf
Hansmann, Martin-Leo
Hartmann, Sylvia
JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title_full JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title_fullStr JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title_full_unstemmed JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title_short JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
title_sort junb, dusp2, sgk1, socs1 and crebbp are frequently mutated in t-cell/histiocyte-rich large b-cell lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355500/
https://www.ncbi.nlm.nih.gov/pubmed/30213827
http://dx.doi.org/10.3324/haematol.2018.203224
work_keys_str_mv AT schuhmacherbianca junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT beinjulia junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT rauschtobias junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT benesvladimir junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT tousseynthomas junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT vornanenmartine junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT ponzonimaurilio junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT thurnerlorenz junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT gascoynerandy junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT steidlchristian junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT kuppersralf junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT hansmannmartinleo junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma
AT hartmannsylvia junbdusp2sgk1socs1andcrebbparefrequentlymutatedintcellhistiocyterichlargebcelllymphoma